NASDAQ
Helix BioPharma Corp. (HBPCF) has a interest coverage ratio of -502.82x as of Friday, May 29, 2026. This represents a 38.16% decrease compared to its 12-month average of -363.94x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.